{"id":6371,"date":"2018-04-20T18:40:00","date_gmt":"2018-04-20T16:40:00","guid":{"rendered":"https:\/\/www.osatzen.com\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/"},"modified":"2021-06-07T13:16:29","modified_gmt":"2021-06-07T11:16:29","slug":"canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares","status":"publish","type":"post","link":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/","title":{"rendered":"Canaglifozina en la prevenci\u00f3n primaria y secundaria de eventos cardiovasculares"},"content":{"rendered":"<table cellpadding=\"0\" cellspacing=\"0\" style=\"float: left; margin-right: 1em; text-align: left;\">\n<tbody>\n<tr>\n<td style=\"text-align: center;\"><a href=\"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg\" style=\"clear: left; margin-bottom: 1em; margin-left: auto; margin-right: auto;\"><img decoding=\"async\" border=\"0\" data-original-height=\"283\" data-original-width=\"300\" src=\"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg\" \/><\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\">La imagen es de <a href=\"http:\/\/www.iqb.es\/cbasicas\/farma\/farma04\/c140.html\" target=\"_blank\" rel=\"noopener\">aqu\u00ed<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Nuestro compa\u00f1ero Mikel Moreno ha realizado la lectura cr\u00edtica del art\u00edculo <a href=\"http:\/\/circ.ahajournals.org\/content\/137\/4\/323\" target=\"_blank\" rel=\"noopener\">Canagliflozin for Primary and Secondary Prevention of Cardiovascular Event. <\/a><br \/>y, con las sugerencias de algunos miembros del grupo, redactado el CAT.<\/p>\n<p>La conclusi\u00f3n es la siguiente:<\/p>\n<p><span style=\"color: blue;\"><b><i>La canaglifozina no es efectiva en la prevenci\u00f3n primaria de eventos cardiovasculares en diab\u00e9ticos tipo 2. En la prevenci\u00f3n secundaria tiene una efectividad limitada y efectos secundarios frecuentes.<\/i><\/b><\/span><\/p>\n<p>Os dejamos tambi\u00e9n el CAT.<\/p>\n<p><b><\/b><br \/><b><br \/><\/b><b><br \/><\/b><iframe allowfullscreen=\"\" frameborder=\"0\" height=\"714\" marginheight=\"0\" marginwidth=\"0\" scrolling=\"no\" src=\"\/\/www.slideshare.net\/slideshow\/embed_code\/key\/CExarKwDKmUIiN\" style=\"border-width: 1px; border: 1px solid #ccc; margin-bottom: 5px; max-width: 100%;\" width=\"668\"> <\/iframe> <\/p>\n<div style=\"margin-bottom: 5px;\"><b> <\/b> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>La imagen es de aqu\u00ed Nuestro compa\u00f1ero Mikel Moreno ha realizado la lectura cr\u00edtica del art\u00edculo Canagliflozin for Primary and Secondary Prevention of Cardiovascular Event. y, con las sugerencias de algunos miembros del grupo, redactado  [&#8230;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":""},"categories":[624,597,592],"tags":[],"class_list":["post-6371","post","type-post","status-publish","format-standard","hentry","category-blog-salabardo-mbe","category-diabeticos-tipo-2","category-tratamiento"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.3 (Yoast SEO v25.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Canaglifozina en la prevenci\u00f3n primaria y secundaria de eventos cardiovasculares - Osatzen<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/\" \/>\n<meta property=\"og:locale\" content=\"eu_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Canaglifozina en la prevenci\u00f3n primaria y secundaria de eventos cardiovasculares\" \/>\n<meta property=\"og:description\" content=\"La imagen es de aqu\u00ed Nuestro compa\u00f1ero Mikel Moreno ha realizado la lectura cr\u00edtica del art\u00edculo Canagliflozin for Primary and Secondary Prevention of Cardiovascular Event. y, con las sugerencias de algunos miembros del grupo, redactado [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/\" \/>\n<meta property=\"og:site_name\" content=\"Osatzen\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Osatzen\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-20T16:40:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-07T11:16:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg\" \/>\n<meta name=\"author\" content=\"BLOG EL SALABARDO - MBE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@osatzen\" \/>\n<meta name=\"twitter:site\" content=\"@osatzen\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BLOG EL SALABARDO - MBE\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/\"},\"author\":{\"name\":\"BLOG EL SALABARDO - MBE\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/59f76d6c5831dff8ca4050643ea3aedb\"},\"headline\":\"Canaglifozina en la prevenci\u00f3n primaria y secundaria de eventos cardiovasculares\",\"datePublished\":\"2018-04-20T16:40:00+00:00\",\"dateModified\":\"2021-06-07T11:16:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/\"},\"wordCount\":93,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg\",\"articleSection\":[\"BLOG SALABARDO MBE\",\"diab\u00e9ticos tipo 2\",\"tratamiento\"],\"inLanguage\":\"eu-ES\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/\",\"url\":\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/\",\"name\":\"Canaglifozina en la prevenci\u00f3n primaria y secundaria de eventos cardiovasculares - Osatzen\",\"isPartOf\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg\",\"datePublished\":\"2018-04-20T16:40:00+00:00\",\"dateModified\":\"2021-06-07T11:16:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#breadcrumb\"},\"inLanguage\":\"eu-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"eu-ES\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#primaryimage\",\"url\":\"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg\",\"contentUrl\":\"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.osatzen.com\/eu\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Canaglifozina en la prevenci\u00f3n primaria y secundaria de eventos cardiovasculares\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#website\",\"url\":\"https:\/\/www.osatzen.com\/eu\/\",\"name\":\"Osatzen\",\"description\":\"Sociedad Vasca de Medicina de Familia y Comunitaria\",\"publisher\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.osatzen.com\/eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"eu-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#organization\",\"name\":\"Osatzen\",\"url\":\"https:\/\/www.osatzen.com\/eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu-ES\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.osatzen.com\/wp-content\/uploads\/2021\/02\/signo-distintivo-osatzen-2020-web-retina-396x120-1.png\",\"contentUrl\":\"https:\/\/www.osatzen.com\/wp-content\/uploads\/2021\/02\/signo-distintivo-osatzen-2020-web-retina-396x120-1.png\",\"width\":396,\"height\":120,\"caption\":\"Osatzen\"},\"image\":{\"@id\":\"https:\/\/www.osatzen.com\/eu\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Osatzen\",\"https:\/\/x.com\/osatzen\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/59f76d6c5831dff8ca4050643ea3aedb\",\"name\":\"BLOG EL SALABARDO - MBE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu-ES\",\"@id\":\"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2af25a14e5da1c9bfb0a6c9ac7cbdce7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2af25a14e5da1c9bfb0a6c9ac7cbdce7?s=96&d=mm&r=g\",\"caption\":\"BLOG EL SALABARDO - MBE\"},\"description\":\"La idea de este blog es favorecer la ense\u00f1anza y pr\u00e1ctica de la medicina basada en la evidencia (MBE) . En \u00e9l podr\u00e1n encontrarse materiales elaborados por el grupo MBE Osatzen en forma de respuestas a dudas cl\u00ednicas y metodol\u00f3gicas, evaluaciones de art\u00edculos originales, etc, Pero el blog podr\u00e1 recoger cualquier otra iniciativa de inter\u00e9s relacionada con la mejora de la pr\u00e1ctica cl\u00ednica en atenci\u00f3n primaria.\",\"url\":\"https:\/\/www.osatzen.com\/eu\/blogs\/author\/blogelsalabardo\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Canaglifozina en la prevenci\u00f3n primaria y secundaria de eventos cardiovasculares - Osatzen","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/","og_locale":"eu_ES","og_type":"article","og_title":"Canaglifozina en la prevenci\u00f3n primaria y secundaria de eventos cardiovasculares","og_description":"La imagen es de aqu\u00ed Nuestro compa\u00f1ero Mikel Moreno ha realizado la lectura cr\u00edtica del art\u00edculo Canagliflozin for Primary and Secondary Prevention of Cardiovascular Event. y, con las sugerencias de algunos miembros del grupo, redactado [...]","og_url":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/","og_site_name":"Osatzen","article_publisher":"https:\/\/www.facebook.com\/Osatzen","article_published_time":"2018-04-20T16:40:00+00:00","article_modified_time":"2021-06-07T11:16:29+00:00","og_image":[{"url":"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg","type":"","width":"","height":""}],"author":"BLOG EL SALABARDO - MBE","twitter_card":"summary_large_image","twitter_creator":"@osatzen","twitter_site":"@osatzen","twitter_misc":{"Written by":"BLOG EL SALABARDO - MBE"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#article","isPartOf":{"@id":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/"},"author":{"name":"BLOG EL SALABARDO - MBE","@id":"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/59f76d6c5831dff8ca4050643ea3aedb"},"headline":"Canaglifozina en la prevenci\u00f3n primaria y secundaria de eventos cardiovasculares","datePublished":"2018-04-20T16:40:00+00:00","dateModified":"2021-06-07T11:16:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/"},"wordCount":93,"commentCount":0,"publisher":{"@id":"https:\/\/www.osatzen.com\/eu\/#organization"},"image":{"@id":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#primaryimage"},"thumbnailUrl":"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg","articleSection":["BLOG SALABARDO MBE","diab\u00e9ticos tipo 2","tratamiento"],"inLanguage":"eu-ES","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/","url":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/","name":"Canaglifozina en la prevenci\u00f3n primaria y secundaria de eventos cardiovasculares - Osatzen","isPartOf":{"@id":"https:\/\/www.osatzen.com\/eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#primaryimage"},"image":{"@id":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#primaryimage"},"thumbnailUrl":"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg","datePublished":"2018-04-20T16:40:00+00:00","dateModified":"2021-06-07T11:16:29+00:00","breadcrumb":{"@id":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#breadcrumb"},"inLanguage":"eu-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/"]}]},{"@type":"ImageObject","inLanguage":"eu-ES","@id":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#primaryimage","url":"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg","contentUrl":"https:\/\/osatzen.com\/wp-content\/uploads\/2021\/06\/canaliflozina.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.osatzen.com\/eu\/blogs\/canaglifozina-en-la-prevencion-primaria-y-secundaria-de-eventos-cardiovasculares\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.osatzen.com\/eu\/"},{"@type":"ListItem","position":2,"name":"Canaglifozina en la prevenci\u00f3n primaria y secundaria de eventos cardiovasculares"}]},{"@type":"WebSite","@id":"https:\/\/www.osatzen.com\/eu\/#website","url":"https:\/\/www.osatzen.com\/eu\/","name":"Osatzen","description":"Sociedad Vasca de Medicina de Familia y Comunitaria","publisher":{"@id":"https:\/\/www.osatzen.com\/eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.osatzen.com\/eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"eu-ES"},{"@type":"Organization","@id":"https:\/\/www.osatzen.com\/eu\/#organization","name":"Osatzen","url":"https:\/\/www.osatzen.com\/eu\/","logo":{"@type":"ImageObject","inLanguage":"eu-ES","@id":"https:\/\/www.osatzen.com\/eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.osatzen.com\/wp-content\/uploads\/2021\/02\/signo-distintivo-osatzen-2020-web-retina-396x120-1.png","contentUrl":"https:\/\/www.osatzen.com\/wp-content\/uploads\/2021\/02\/signo-distintivo-osatzen-2020-web-retina-396x120-1.png","width":396,"height":120,"caption":"Osatzen"},"image":{"@id":"https:\/\/www.osatzen.com\/eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Osatzen","https:\/\/x.com\/osatzen"]},{"@type":"Person","@id":"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/59f76d6c5831dff8ca4050643ea3aedb","name":"BLOG EL SALABARDO - MBE","image":{"@type":"ImageObject","inLanguage":"eu-ES","@id":"https:\/\/www.osatzen.com\/eu\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2af25a14e5da1c9bfb0a6c9ac7cbdce7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2af25a14e5da1c9bfb0a6c9ac7cbdce7?s=96&d=mm&r=g","caption":"BLOG EL SALABARDO - MBE"},"description":"La idea de este blog es favorecer la ense\u00f1anza y pr\u00e1ctica de la medicina basada en la evidencia (MBE) . En \u00e9l podr\u00e1n encontrarse materiales elaborados por el grupo MBE Osatzen en forma de respuestas a dudas cl\u00ednicas y metodol\u00f3gicas, evaluaciones de art\u00edculos originales, etc, Pero el blog podr\u00e1 recoger cualquier otra iniciativa de inter\u00e9s relacionada con la mejora de la pr\u00e1ctica cl\u00ednica en atenci\u00f3n primaria.","url":"https:\/\/www.osatzen.com\/eu\/blogs\/author\/blogelsalabardo\/"}]}},"_links":{"self":[{"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/posts\/6371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/comments?post=6371"}],"version-history":[{"count":1,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/posts\/6371\/revisions"}],"predecessor-version":[{"id":6468,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/posts\/6371\/revisions\/6468"}],"wp:attachment":[{"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/media?parent=6371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/categories?post=6371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.osatzen.com\/eu\/wp-json\/wp\/v2\/tags?post=6371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}